Which Progenitor is the Target Cell in the Development of Acute Promyelocytic Leukemia?

References

• Fialkow P. J., Singer J. W., Raskind W. H., Adamson J. W., Jacobson R. J., Bernstein I. D., Dow L. W., Najfeld V., Veith R. Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N. Eng. J. Med. 1987; 317: 468–473
   PubMed Web of Science ®Google Scholar
• Bernstein I. D., Singer J. W., Smith F. O., Andrews R. G., Flowers D. A., Petersens J., Steinmann L., Najfeld V., Savage D., Fruchtman S., Arlin Z., Fialkow P. J. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Blood. 1992; 79b: 1811–1816
   Google Scholar
• Fialkow P. J., Jacobson R. J., Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med. 1977; 63: 125–130
   PubMed Web of Science ®Google Scholar
• Dube I. D., Gupta C. M., Kalousek D. K., Eaves C. J., Eaves A. C. Cytogenetic studies of early myeloid progenitors compartments in Ph1-positive chronic myeloid leukemia. Br. J. Haematol. 1984; 56: 633–644
   PubMed Web of Science ®Google Scholar
• Hernandez A., Osterholtz J., Price C. M., Wiedermann L. M., Gordon M. Y., Goldman J. M., Morgan G. J. Detection of the hybrid BCR/ABL messenger RNA in single CFU-GM colonies using the polymerase chain reaction. Exp. Hematol 1990; 18: 1142–1144
   PubMed Web of Science ®Google Scholar
• Sadamura S., Umemura T., Takahira H., Hirata J., Nishimura J., Nawata H. Analysis of clonality at the level of progenitors in chronic myelogenous leukemia using the polymerase chain reaction. Leukemia Res. 1992; 16: 371–377
   PubMed Web of Science ®Google Scholar
• Sadamura S., Umemura T., Hirata J., Takahira H., Yufu Y., Abe Y., Nishimura J., Nawata H. P190-type bcr/abl expressed in myeloid colonies in patient with Ph'-positive acute lymphoblastic leukemia. Leukemia 1992; 6: 791–795
   PubMed Web of Science ®Google Scholar
• de The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Borrow J., Goddard A. D., Sheer D., Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region of chromosome 17. Science 1990; 249: 1577–1580
   PubMed Web of Science ®Google Scholar
• Alcalay M., Zangrilli D., Pandolfi P. P., Longo L., Mercarelli A., Giacomucci A., Rocchi M., Biondi A., Rambaldi A., Coco F. L., Diverio D., Donti E., Grignani F., Pellici P. G. Translocation breakpoint of promyelocytic leukemia lies within the retinoic acid receptor a locus. Proc. Natl. Acad. Sci. USA 1991; 88: 1977–1981
   PubMed Web of Science ®Google Scholar
• de The H., Lavau C., Marchio A., Chomienne C., Lantte M., Degos L., Dejean A. The PML/RAR a fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675–684
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W. H., Umesono K., Warrel R. P., Frankel S. R., Murty V. V. V. S., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15;17) in human promyelocytic leukemia fuses RAR a with a novel putative transcription factor, PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• Pandolfi P. P., Alcalay M., Fangioli M., Zangrilli D., Mencarelli A., Biondi A., Coco F. I., Rambaldi A., Grignani F., Rochette-Egly C., Graube M.-P., Chambon P., Pelicci P. G. Genomic variability and alternative splicing generate multiple PML/RAR a transcripts that encode aberrant PML proteins and PML/RAR a isoforms in acute promyelocyte leukemia. EMBO J. 1992; 11: 1397–1407
   PubMed Web of Science ®Google Scholar
• Biondi A., Rambaldi A., Pandolfi P. P., Rossi V., Giudici G., Alcalay M., Coco F. L., Diverio D., Pogliani M., Lanzi E. M., Mandelli F., Masera G., Barbui T., Pelicci P. G. Molecular monitoring of the myl/retinoic acid receptor-cc fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992; 80: 492–497
   PubMed Web of Science ®Google Scholar
• Chen S.-J., Chen Z., Chen A., Tong J.-H., Dong S., Wang Z. Y., Waxman S., Zelent A. Occurrence of distinct PML/RAR α fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. Oncogene 1992; 7: 1223–1232
   PubMed Web of Science ®Google Scholar
• Miller W. H., Jr., Kristi L., De Blasio A., Frankel S. R., Dmitrovsky E., Warrell R. P., Jr. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-rx fusion mRNA. Blood 1993; 82: 1689–1694
   PubMed Web of Science ®Google Scholar
• Huang W., Sun G.-L., Li X.-S., Cao Q., Lu Y., Jang G.-S., Zhang F.-Q., Chai J.-R., Wang Z.-Y., Waxman S., Chen Z., Chen S.-J. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR α isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 1993; 82: 1264–1269
   PubMed Web of Science ®Google Scholar
• Huang M., Ye Y. C., Chen B. R., Chai J. R., Lu J. X., Zhao L., Gu L. J., Wang Z. Y. Use of all-trans-retinoic acid treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572
   PubMed Web of Science ®Google Scholar
• Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. 1. Clinical results. Blood 1990; 76: 1704–1709
   PubMed Web of Science ®Google Scholar
• Chomienne C., Balitrand N., Ballerini P., Castaigne S., de The H., Degos L. All-trans retinoic acid modulates the retinoic acid receptor-a in promyelocytic cells. J. Clin. Invest. 1991; 88: 2150–2154
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Avvisati G., Diverio D., Petti M. C., Alcalay M., Pandolfi P. P., Zangrilli D., Rambaldi A., Moleti M., Mandelli F., Pelicci P. G. Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemia. Blood 1991; 77: 1657–1659
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Frankel S. R., Miller W. H., Sheiberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreef M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S., Dimitrovski E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (alltrans-retinoic acid). N. Eng. J. Med. 1991; 324: 1385–1393
   PubMed Web of Science ®Google Scholar
• Takatsuki H., Sadamura S., Umemura T., Abe Y., Goto T., Yufu Y., Katsuno M., Hirata J., Nishimura J., Nawata H. PML/RAR α fusion gene is expressed in both granuloid/macrophage and erythroid colonies in acute promyelocytic leukaemia. Br. J. Haematol. 1993; 85: 477–482
   PubMed Web of Science ®Google Scholar
• Zaheer H. A., Bagnara M., Gibson F. M., Robinson G., Rutherford T. R., Gordon-Smith E. C. Persistence of an activating N-RAS oncogene mutation in clonogenic progenitor cells from an acute myeloid leukaemia patient in remission. Br. J. Haematol. 1994; 86: 298–302
   PubMed Web of Science ®Google Scholar
• Busque L., Gilliland D. G. Clonal evolution in acute myeloid leukemia. Blood 1994; 82: 337–342
   Web of Science ®Google Scholar
• Koike T., Tatewaki W., Aoki A., Yoshimoto H., Yagisawa K., Hashimoto S., Furukawa T., Saitoh H., Takahashi M., Libo Y., Ying W., Shibata A. Severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Eng. J. Med. 1992; ill: 385–387
   Web of Science ®Google Scholar
• Tallman M. S., Hakimian D., Snower D., Rubin C. M., Reisei H., Variakojis D. Basophilic differentiation in acute promyelocytic leukemia. Leukemia 1993; 7: 521–526
   PubMed Web of Science ®Google Scholar
• Tomonaga M., Yoshida Y., Tagawa M., Jinnai I., Kuriyama K., Amenomori T., Yoshioka A., Matsuo T., Nonaka H., Ichimaru M. Cytochemistry of acute promyelocytic leukemia (M3): leukemic promyelocytes exhibit heterogeneous patterns in cellular differentiation. Blood 1985; 66: 350–357
   PubMed Web of Science ®Google Scholar
• Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Grignani F., Pelicci P. G. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994; 83: 10–25
   PubMed Web of Science ®Google Scholar